OXFORD BIOMEDICA LS-,50/ GB00BDFBVT43 /
2024-11-14 11:13:31 AM | Chg. -0.130 | Volume | Bid11:13:42 AM | Ask11:13:42 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
4.920EUR | -2.57% | - Turnover: - |
4.880Bid Size: 101 | 5.000Ask Size: 101 | 392.9 mill.EUR | - | - |
Assets
|
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 27.5000 | 25.4000 | 31.8000 | 61.9000 | 72.3000 | ||||||
Intangible Assets | 1.3000 | .1000 | .1000 | .1000 | .0700 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 2.2000 | 3.3000 | 4.3000 | 2.6000 | 6.9000 | ||||||
Accounts Receivable | 2 | 5.7000 | 15.4000 | 12.8000 | 53.9000 | ||||||
Cash and Cash Equivalents | 15.3000 | 14.3000 | 32.2000 | 16.2000 | 46.7000 | ||||||
Current Assets | 27.4000 | 37 | 69.5000 | 56.9000 | 107.9000 | ||||||
Total Assets | 56.9000 | 65.4000 | 112.4000 | 122.9000 | 183.9000 |
Liabilities
|
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1.6000 | 8.7000 | 11.4000 | 14.3000 | 19.7000 | ||||||
Long-term debt | 34.4000 | 36.9000 | 41.2000 | - | - | ||||||
Liabilities to Banks | 34.4000 | 36.9000 | 41.2000 | 0.0000 | 0.0000 | ||||||
Provisions | .6000 | .6000 | 1.6000 | 5.5000 | 5.8000 | ||||||
Liabilities | 44.3000 | 59.3000 | 77.7000 | 47.3000 | 71.2000 | ||||||
Share Capital | 30.8790 | 31.0760 | 33.0340 | 38.4160 | 41.1610 | ||||||
Total Equity | 12.6000 | 6.1000 | 34.7000 | 75.6000 | 112.7000 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 56.9000 | 65.4000 | 112.4000 | 122.9000 | 183.9000 |
Income Statement
|
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 27.8000 | 37.6000 | 66.8000 | 64.1000 | 87.7000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -11.3000 | -5.7000 | 13.9000 | -14.5000 | -5.7000 | ||||||
Interest Income | -8.9700 | -6.0600 | -8.9300 | -6.4000 | -.8700 | ||||||
Income Before Taxes | -20.3000 | -11.8000 | 5 | -20.9000 | -6.6000 | ||||||
Income Taxes | -3.7000 | -2.7000 | -2.5000 | -4.8000 | -.3000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | -16.6000 | -9 | 7.5000 | -16.1000 | -6.2000 |
Per Share
Cash Flow
|
2016 IFRS in mill. GBP |
2017 IFRS in mill. GBP |
2018 IFRS in mill. GBP |
2019 IFRS in mill. GBP |
2020 IFRS in mill. GBP |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -5.1000 | 3 | 12.9000 | -3.5000 | 3.1000 | ||||||
Cash Flow from Investing Activities | -6.4000 | -1.9000 | -10.1000 | -19.4000 | -10.8000 | ||||||
Cash Flow from Financing | 17.5000 | -2.1000 | 15.1000 | 6.9000 | 38.2000 | ||||||
Decrease / Increase in Cash | 6 | -1 | 17.9000 | -16 | 30.5000 | ||||||
Employees | 256 | 321 | 432 | 554 | 673 |